Indeed, depending upon which signaling pathway is activated (JAK-STAT or Hippo), LIF has been proposed as being pro- or anti-tumoral, as recently demonstrated in gastric cancer stem cell models [21,29,49]. The gene discussed is LIF; the disease is gastric cancer.